Atazanavir-Mepha 150 mg
Atazanavir-Mepha 150 mg is a medicine authorised by Swissmedic under authorisation number 66339. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 September 2017 and the authorisation is valid without a time limit. ATC code J05AE08 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 66339 |
|---|---|
| Name | Atazanavir-Mepha 150 mg |
| Full name | Atazanavir-Mepha 150 mg, Hartkapseln |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J05AE08 |
| First authorisation | 19 September 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Atazanavir-Mepha 150 mg, Hartkapseln | A | 19 September 2017 |
| 2 | Atazanavir-Mepha 200 mg, Hartkapseln | A | 19 September 2017 |
| 3 | Atazanavir-Mepha 300 mg, Hartkapseln | A | 19 September 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Kapsel(n) | J05AE08 | 08.03.0. | A |
| 2 | 60 | Kapsel(n) | J05AE08 | 08.03.0. | A |
| 3 | 30 | Kapsel(n) | J05AE08 | 08.03.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Atazanavir-Mepha 150 mg authorised in Switzerland?
Yes. Atazanavir-Mepha 150 mg is authorised by Swissmedic under authorisation number 66339, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Atazanavir-Mepha 150 mg have?
Atazanavir-Mepha 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Atazanavir-Mepha 150 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.